M&A Dynamics in Medical Aesthetics.
Medical Aesthetics which was predicted to exceed $13 bn in 2021 has continued to show significant resilience, its recovery is ramping up as lock-down measures recede globally confirming the relevance of Medical Aesthetics as sustainable, resilient and essential procedures. We also observe a Flight to safety and quality, minimally invasive, needle-free and no downtime procedures with the ease of injections without oedemas or granulomas or hematomas becoming an overarching priority in the COVID-traumatized environment, as well as novel forms of connected syringes to standardize injections. The Holy Grail of BDDE Free injections has generated a number of cutting-edge innovations.
